EVOKE PHARMA, INC. Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31)
EVOKE PHARMA, INC. had Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) of $25.65 million as of 2014-03-31, per its 10-Q filed 2014-05-13.
Discontinued › Notes
us-gaap:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage · last filed 2014-05-13
- 2014-03-31: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $25.65M.
- 2013-12-31: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $22.69M.
- 2013-09-30: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $21.07M.
- 2012-12-31: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $19.86M.
| Period end | Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) |
|---|---|
| 2014-03-31 | $25.65M 10-Q · filed 2014-05-13 |
| 2013-12-31 | $22.69M 10-Q · filed 2014-05-13 |
| 2013-09-30 | $21.07M 10-Q · filed 2013-11-13 |
| 2012-12-31 | $19.86M 10-K · filed 2014-03-25 |